Cite
Economic Evaluation of Factorial Trials: Cost-Utility Analysis of the Atorvastatin in Factorial With Omega EE90 Risk Reduction in Diabetes 2 × 2 × 2 Factorial Trial of Atorvastatin, Omega-3 Fish Oil, and Action Planning.
MLA
Dakin, Helen A., et al. “Economic Evaluation of Factorial Trials: Cost-Utility Analysis of the Atorvastatin in Factorial With Omega EE90 Risk Reduction in Diabetes 2 × 2 × 2 Factorial Trial of Atorvastatin, Omega-3 Fish Oil, and Action Planning.” Value in Health, vol. 23, no. 10, Oct. 2020, pp. 1340–48. EBSCOhost, https://doi.org/10.1016/j.jval.2020.05.018.
APA
Dakin, H. A., Farmer, A., Gray, A. M., & Holman, R. R. (2020). Economic Evaluation of Factorial Trials: Cost-Utility Analysis of the Atorvastatin in Factorial With Omega EE90 Risk Reduction in Diabetes 2 × 2 × 2 Factorial Trial of Atorvastatin, Omega-3 Fish Oil, and Action Planning. Value in Health, 23(10), 1340–1348. https://doi.org/10.1016/j.jval.2020.05.018
Chicago
Dakin, Helen A., Andrew Farmer, Alastair M. Gray, and Rury R. Holman. 2020. “Economic Evaluation of Factorial Trials: Cost-Utility Analysis of the Atorvastatin in Factorial With Omega EE90 Risk Reduction in Diabetes 2 × 2 × 2 Factorial Trial of Atorvastatin, Omega-3 Fish Oil, and Action Planning.” Value in Health 23 (10): 1340–48. doi:10.1016/j.jval.2020.05.018.